Current state of radiomics in hepatobiliary and pancreatic malignancies

Abstract

Rising in incidence, hepatobiliary and pancreatic (HPB) cancers continue to exhibit dismal long-term survival. The overall poor prognosis of HPB cancers is reflective of the advanced stage at which most patients are diagnosed. Late diagnosis is driven by the often-asymptomatic nature of these diseases, as well as a dearth of screening modalities. Additionally, standard imaging modalities fall short of providing accurate and detailed information regarding specific tumor characteristics, which can better inform surgical planning and sequencing of systemic therapy. Therefore, precise therapeutic planning must be delayed until histopathological examination is performed at the time of resection. Given the current shortcomings in the management of HPB cancers, investigations of numerous noninvasive biomarkers, including circulating tumor cells and DNA, proteomics, immunolomics, and radiomics, are underway. Radiomics encompasses the extraction and analysis of quantitative imaging features. Along with summarizing the general framework of radiomics, this review synthesizes the state of radiomics in HPB cancers, outlining its role in various aspects of management, present limitations, and future applications for clinical integration. Current literature underscores the utility of radiomics in early detection, tumor characterization, therapeutic selection, and prognostication for HPB cancers. Seeing as single-center, small studies constitute the majority of radiomics literature, there is considerable heterogeneity with respect to steps of the radiomics workflow such as segmentation, or delineation of the region of interest on a scan. Nonetheless, the introduction of the radiomics quality score (RQS) demonstrates a step towards greater standardization and reproducibility in the young field of radiomics. Altogether, in the setting of continually improving artificial intelligence algorithms, radiomics represents a promising biomarker avenue for promoting enhanced and tailored management of HPB cancers, with the potential to improve long-term outcomes for patients.

Keywords

Pancreatic neoplasms / pancreatic ductal adenocarcinoma / hepatocellular carcinoma / cholangiocarcinoma / radiomics / artificial intelligence

References

[1] Rawla P,Gaduputi V.Epidemiology of pancreatic cancer: global trends, etiology and risk factors.World J Oncol2019;10:10-27 PMCID:PMC6396775

[2] Bridgewater J,Wasan H.Prognostic factors for progression-free and overall survival in advanced biliary tract cancer.Ann Oncol2016;27:134-40

[3] Huang L,Balavarca Y.Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study.BMC Med2018;16:125 PMCID:PMC6102804

[4] Brar G,Graubard BI.Hepatocellular carcinoma survival by etiology: a SEER-medicare database analysis.Hepatol Commun2020;4:1541-51 PMCID:PMC7527688

[5] Mittal S.Epidemiology of hepatocellular carcinoma: consider the population.J Clin Gastroenterol2013;47 Suppl:S2-6 PMCID:PMC3683119

[6] Zhang L,Stoita A.Challenges in diagnosis of pancreatic cancer.World J Gastroenterol2018;24:2047-60 PMCID:PMC5960811

[7] Wang W.Advances in the early diagnosis of hepatocellular carcinoma.Genes Dis2020;7:308-19 PMCID:PMC7452544

[8] Kennedy T,Stocker SJ.Incidence of benign inflammatory disease in patients undergoing Whipple procedure for clinically suspected carcinoma: a single-institution experience.Am J Surg2006;191:437-41

[9] Piñero F,Pessôa MG.Biomarkers in hepatocellular carcinoma: diagnosis, prognosis and treatment response assessment.Cells2020;9:1370 PMCID:PMC7349517

[10] Singhi AD,Chari ST.Early detection of pancreatic cancer: opportunities and challenges.Gastroenterology2019;156:2024-40 PMCID:PMC6486851

[11] Buchs NC,Poletti PA,Morel P.Vascular invasion in pancreatic cancer: Imaging modalities, preoperative diagnosis and surgical management.World J Gastroenterol2010;16:818-31 PMCID:PMC2825328

[12] Rehders A,Güray A,Alexander A.Vascular invasion in pancreatic cancer: tumor biology or tumor topography?.Surgery2012;152:S143-51

[13] Dayimu A,Anand S.Clinical and biological markers predictive of treatment response associated with metastatic pancreatic adenocarcinoma.Br J Cancer2023;128:1672-80 PMCID:PMC10133256

[14] Sturm N,Perkhofer L.The impact of biomarkers in pancreatic ductal adenocarcinoma on diagnosis, surveillance and therapy.Cancers2022;14:217 PMCID:PMC8750069

[15] Zhang WH,Han X.Advances on diagnostic biomarkers of pancreatic ductal adenocarcinoma: a systems biology perspective.Comput Struct Biotechnol J2020;18:3606-14 PMCID:PMC7710502

[16] Herreros-Villanueva M.Non-invasive biomarkers in pancreatic cancer diagnosis: what we need versus what we have.Ann Transl Med2016;4:134 PMCID:PMC4842402

[17] Boilève A,Delaye M,Neuzillet C.Biomarkers in hepatobiliary cancers: what is useful in clinical practice?.Cancers2021;13:2708 PMCID:PMC8198554

[18] Sarhadi VK.Molecular biomarkers in cancer.Biomolecules2022;12:1021 PMCID:PMC9331210

[19] Gillies RJ,Hricak H.Radiomics: images are more than pictures, they are data.Radiology2016;278:563-77 PMCID:PMC4734157

[20] Karmazanovsky G,Tikhonova V,Revishvili A.Computed tomography-based radiomics approach in pancreatic tumors characterization.Radiol Med2021;126:1388-95

[21] Mori M,Partelli S.Ct radiomic features of pancreatic neuroendocrine neoplasms (panNEN) are robust against delineation uncertainty.Phys Med2019;57:41-6

[22] van Timmeren JE, Cester D, Tanadini-Lang S, Alkadhi H, Baessler B. Radiomics in medical imaging-“how-to” guide and critical reflection.Insights Imaging2020;11:91 PMCID:PMC7423816

[23] Pavic M,Würms X.Influence of inter-observer delineation variability on radiomics stability in different tumor sites.Acta Oncol2018;57:1070-4

[24] Siegel RL,Wagle NS.Cancer statistics, 2023.CA Cancer J Clin2023;73:17-48

[25] Habib JR,van Oosten F.Periadventitial dissection of the superior mesenteric artery for locally advanced pancreatic cancer: surgical planning with the “halo sign” and “string sign”.Surgery2021;169:1026-31

[26] Kinny-Köster B,Wolfgang CL,Javed AA.Favorable tumor biology in locally advanced pancreatic cancer-beyond CA19-9.J Gastrointest Oncol2021;12:2484-94 PMCID:PMC8576224

[27] Chen PT,Yen H.Radiomic features at CT can distinguish pancreatic cancer from noncancerous pancreas.Radiol Imaging Cancer2021;3:e210010 PMCID:PMC8344348

[28] Chu LC,Kawamoto S.Utility of CT radiomics features in differentiation of pancreatic ductal adenocarcinoma from normal pancreatic tissue.AJR Am J Roentgenol2019;213:349-57

[29] Qiu JJ,Qian W.A novel multiresolution-statistical texture analysis architecture: radiomics-aided diagnosis of PDAC based on plain CT images.IEEE Trans Med Imaging2021;40:12-25

[30] Park S,Hruban RH.Differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma with CT radiomics features.Diagn Interv Imaging2020;101:555-64

[31] Ren S,Zhang J.Diagnostic accuracy of unenhanced CT texture analysis to differentiate mass-forming pancreatitis from pancreatic ductal adenocarcinoma.Abdom Radiol2020;45:1524-33

[32] Zhang Y,Liu Z.Radiomics analysis for the differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma in ¹⁸F-FDG PET/CT.Med Phys2019;46:4520-30

[33] Ziegelmayer S,Harder F.Deep convolutional neural network-assisted feature extraction for diagnostic discrimination and feature visualization in pancreatic ductal adenocarcinoma (PDAC) versus autoimmune pancreatitis (AIP).J Clin Med2020;9:4013 PMCID:PMC7764649

[34] E L,Wu Z.Differentiation of focal-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma using radiomics based on multiphasic computed tomography.J Comput Assist Tomogr2020;44:511-8 PMCID:PMC9165686

[35] Guo C,Wang Q.The differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma: the values of CT imaging features and texture analysis.Cancer Imaging2018;18:37 PMCID:PMC6192319

[36] He M,Lin Y.Differentiation of atypical non-functional pancreatic neuroendocrine tumor and pancreatic ductal adenocarcinoma using CT based radiomics.Eur J Radiol2019;117:102-11

[37] Li J,Liang P.Differentiation of atypical pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas: using whole-tumor CT texture analysis as quantitative biomarkers.Cancer Med2018;7:4924-31 PMCID:PMC6198241

[38] Shi YJ,Liu YL.Radiomics analysis based on diffusion kurtosis imaging and T2 weighted imaging for differentiation of pancreatic neuroendocrine tumors from solid pseudopapillary tumors.Front Oncol2020;10:1624 PMCID:PMC7473210

[39] Amedei A,Prisco D.Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.Hum Vaccin Immunother2014;10:3354-68 PMCID:PMC4514060

[40] Jeon SK,Joo I.Nonhypervascular pancreatic neuroendocrine tumors: differential diagnosis from pancreatic ductal adenocarcinomas at MR imaging-retrospective cross-sectional study.Radiology2017;284:77-87

[41] Ahmed TM,Hruban RH,Soyer P.A primer on artificial intelligence in pancreatic imaging.Diagn Interv Imaging2023;104:435-47

[42] Wei R,Yan W.Computer-aided diagnosis of pancreas serous cystic neoplasms: a radiomics method on preoperative MDCT images.Technol Cancer Res Treat2019;18:1533033818824339 PMCID:PMC6374001

[43] Xie H,Guo X,Wang X.Preoperative differentiation of pancreatic mucinous cystic neoplasm from macrocystic serous cystic adenoma using radiomics: preliminary findings and comparison with radiological model.Eur J Radiol2020;122:108747

[44] Machicado JD,Krishna SG.Radiomics for the diagnosis and differentiation of pancreatic cystic lesions.Diagnostics2020;10:505 PMCID:PMC7399814

[45] Dmitriev K,Javed AA.Classification of pancreatic cysts in computed tomography images using a random forest and convolutional neural network ensemble. In: Descoteaux M, Maier-hein L, Franz A, Jannin P, Collins DL, Duchesne S, editors. Medical image computing and computer assisted intervention - MICCAI 2017. Cham: Springer International Publishing; 2017. p. 150-8.

[46] Tobaly D,Sartoris R.CT-based radiomics analysis to predict malignancy in patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas.Cancers2020;12:3089 PMCID:PMC7690711

[47] Polk SL,McGettigan MJ.Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to predict malignancy.World J Gastroenterol2020;26:3458-71 PMCID:PMC7327792

[48] Hong SB,Kim JH.Pancreatic cancer CT: prediction of resectability according to NCCN criteria.Radiology2018;289:710-8

[49] Zins M,Cassinotto C.Pancreatic adenocarcinoma staging in the era of preoperative chemotherapy and radiation therapy.Radiology2018;287:374-90

[50] Bian Y,Ma C.Performance of CT-based radiomics in diagnosis of superior mesenteric vein resection margin in patients with pancreatic head cancer.Abdom Radiol2020;45:759-73

[51] Chen F,Qi X.Radiomics-assisted presurgical prediction for surgical portal vein-superior mesenteric vein invasion in pancreatic ductal adenocarcinoma.Front Oncol2020;10:523543 PMCID:PMC7706539

[52] Rigiroli F,Lerebours R.CT radiomic features of superior mesenteric artery involvement in pancreatic ductal adenocarcinoma: a pilot study.Radiology2021;301:610-22 PMCID:PMC9899097

[53] Schlanger D,Popa C,Al Hajjar N.The role of artificial intelligence in pancreatic surgery: a systematic review.Updates Surg2022;74:417-29

[54] Kambakamba P,Herrera PE.The potential of machine learning to predict postoperative pancreatic fistula based on preoperative, non-contrast-enhanced CT: a proof-of-principle study.Surgery2020;167:448-54

[55] Skawran SM,Baessler B.Can magnetic resonance imaging radiomics of the pancreas predict postoperative pancreatic fistula?.Eur J Radiol2021;140:109733

[56] Capretti G,De Palma C.A machine learning risk model based on preoperative computed tomography scan to predict postoperative outcomes after pancreatoduodenectomy.Updates Surg2022;74:235-43

[57] Bian Y,Ma C.CT-based radiomics score for distinguishing between grade 1 and grade 2 nonfunctioning pancreatic neuroendocrine tumors.AJR Am J Roentgenol2020;215:852-63

[58] Bian Y,Cao K.Magnetic resonance imaging radiomic analysis can preoperatively predict G1 and G2/3 grades in patients with NF-pNETs.Abdom Radiol2021;46:667-80

[59] Bian Y,Jiang H.Noncontrast radiomics approach for predicting grades of nonfunctional pancreatic neuroendocrine tumors.J Magn Reson Imaging2020;52:1124-36 PMCID:PMC7895298

[60] Choi TW,Yu MH,Han JK.Pancreatic neuroendocrine tumor: prediction of the tumor grade using CT findings and computerized texture analysis.Acta Radiol2018;59:383-92

[61] Liang W,Huang R.A combined nomogram model to preoperatively predict histologic grade in pancreatic neuroendocrine tumors.Clin Cancer Res2019;25:584-94

[62] Ren S,Cui W.Computed tomography-based radiomics signature for the preoperative differentiation of pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma.Front Oncol2020;10:1618 PMCID:PMC7477956

[63] Xing H,Zhu W.Preoperative prediction of pathological grade in pancreatic ductal adenocarcinoma based on ¹⁸F-FDG PET/CT radiomics.EJNMMI Res2021;11:19

[64] Bian Y,Jiang H.Relationship between radiomics and risk of lymph node metastasis in pancreatic ductal adenocarcinoma.Pancreas2019;48:1195-203 PMCID:PMC6830946

[65] Gao J,Jin Y,Zhang J.A radiomics nomogram for the preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma.Front Oncol2020;10:1654 PMCID:PMC7482654

[66] Li K,Xiao J.Contrast-enhanced CT radiomics for predicting lymph node metastasis in pancreatic ductal adenocarcinoma: a pilot study.Cancer Imaging2020;20:12 PMCID:PMC6993448

[67] Liu P,Hu X.Applying a radiomics-based strategy to preoperatively predict lymph node metastasis in the resectable pancreatic ductal adenocarcinoma.J Xray Sci Technol2020;28:1113-21

[68] Lo Gullo R, Daimiel I, Morris EA, Pinker K. Combining molecular and imaging metrics in cancer: radiogenomics.Insights Imaging2020;11:1 PMCID:PMC6942081

[69] Attiyeh MA,McIntyre CA.CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma.Abdom Radiol2019;44:3148-57 PMCID:PMC6692205

[70] Iwatate Y,Yokota H.Radiogenomics for predicting p53 status, PD-L1 expression, and prognosis with machine learning in pancreatic cancer.Br J Cancer2020;123:1253-61 PMCID:PMC7555500

[71] Kaissis GA,Lohöfer FK.Image-based molecular phenotyping of pancreatic ductal adenocarcinoma.J Clin Med2020;9:724 PMCID:PMC7141256

[72] Lim CH,Choi JY.Imaging phenotype using ¹⁸F-fluorodeoxyglucose positron emission tomography-based radiomics and genetic alterations of pancreatic ductal adenocarcinoma.Eur J Nucl Med Mol Imaging2020;47:2113-22

[73] Nardone V,Grassi R.Delta radiomics: a systematic review.Radiol Med2021;126:1571-83

[74] Chen X,Schott D.Assessment of treatment response during chemoradiation therapy for pancreatic cancer based on quantitative radiomic analysis of daily CTs: An exploratory study.PLoS One2017;12:e0178961 PMCID:PMC5456365

[75] Cusumano D,Yadav P.Delta radiomics analysis for local control prediction in pancreatic cancer patients treated using magnetic resonance guided radiotherapy.Diagnostics2021;11:72 PMCID:PMC7824764

[76] Nasief H,Zheng C.Improving treatment response prediction for chemoradiation therapy of pancreatic cancer using a combination of delta-radiomics and the clinical biomarker CA19-9.Front Oncol2019;9:1464 PMCID:PMC6960122

[77] Nasief H,Schott D.A machine learning based delta-radiomics process for early prediction of treatment response of pancreatic cancer.NPJ Precis Oncol2019;3:25 PMCID:PMC6778189

[78] Simpson G,Dogan N.Predictive value of 0.35 T magnetic resonance imaging radiomic features in stereotactic ablative body radiotherapy of pancreatic cancer: a pilot study.Med Phys2020;47:3682-90

[79] Yue Y,Fraass B.Identifying prognostic intratumor heterogeneity using pre- and post-radiotherapy 18F-FDG PET images for pancreatic cancer patients.J Gastrointest Oncol2017;8:127-38 PMCID:PMC5334038

[80] Li X,Lou J.Preoperative recurrence prediction in pancreatic ductal adenocarcinoma after radical resection using radiomics of diagnostic computed tomography.EClinicalMedicine2022;43:101215 PMCID:PMC8649647

[81] Parr E,Zhang C.Radiomics-based outcome prediction for pancreatic cancer following stereotactic body radiotherapy.Cancers2020;12:1051 PMCID:PMC7226523

[82] Tang TY,Zhang Q.Development of a novel multiparametric MRI radiomic nomogram for preoperative evaluation of early recurrence in resectable pancreatic cancer.J Magn Reson Imaging2020;52:231-45

[83] Wei M,Song S.A novel validated recurrence stratification system based on ¹⁸F-FDG PET/CT radiomics to guide surveillance after resection of pancreatic cancer.Front Oncol2021;11:650266 PMCID:PMC8149949

[84] Marrero JA,Sirlin CB.Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the study of liver diseases.Hepatology2018;68:723-50

[85] Joo I,Yoon JH.Imaging diagnosis of intrahepatic and perihilar cholangiocarcinoma: recent advances and challenges.Radiology2018;288:7-13

[86] Potretzke TA,Doyle MB,Heiken JP.Imaging features of biphenotypic primary liver carcinoma (hepatocholangiocarcinoma) and the potential to mimic hepatocellular carcinoma: LI-RADS analysis of CT and MRI features in 61 cases.AJR Am J Roentgenol2016;207:25-31

[87] Gatos I,Karamesini M.Focal liver lesions segmentation and classification in nonenhanced T2-weighted MRI.Med Phys2017;44:3695-705

[88] Jansen MJA,Veldhuis WB,Viergever MA.Automatic classification of focal liver lesions based on MRI and risk factors.PLoS One2019;14:e0217053 PMCID:PMC6522218

[89] Li Z,Huang W.Texture-based classification of different single liver lesion based on SPAIR T2W MRI images.BMC Med Imaging2017;17:42 PMCID:PMC5508617

[90] Nie P,Guo J.A CT-based radiomics nomogram for differentiation of focal nodular hyperplasia from hepatocellular carcinoma in the non-cirrhotic liver.Cancer Imaging2020;20:20 PMCID:PMC7041197

[91] Wu J,Cui J,Song Q.Radiomics-based classification of hepatocellular carcinoma and hepatic haemangioma on precontrast magnetic resonance images.BMC Med Imaging2019;19:23 PMCID:PMC6417028

[92] Liu X,Namdar K.Can machine learning radiomics provide pre-operative differentiation of combined hepatocellular cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma to inform optimal treatment planning?.Eur Radiol2021;31:244-55

[93] Trivizakis E,Nikiforaki K.Extending 2-D convolutional neural networks to 3-D for advancing deep learning cancer classification with application to MRI liver tumor differentiation.IEEE J Biomed Health Inform2019;23:923-30

[94] Canellas R,Patino M,Sahani D.Characterization of portal vein thrombosis (neoplastic versus bland) on CT images using software-based texture analysis and thrombus density (Hounsfield Units).AJR Am J Roentgenol2016;207:W81-7

[95] Santambrogio R,D’Alessandro V.Micronvasive behaviour of single small hepatocellular carcinoma: which treatment?.Updates Surg2021;73:1359-69

[96] He M,Ma X,Fang C.Radiomic feature-based predictive model for microvascular invasion in patients with hepatocellular carcinoma.Front Oncol2020;10:574228 PMCID:PMC7674833

[97] Ni M,Lv Q.Radiomics models for diagnosing microvascular invasion in hepatocellular carcinoma: which model is the best model?.Cancer Imaging2019;19:60 PMCID:PMC6712704

[98] Qu C,Li C.A radiomics model based on Gd-EOB-DTPA-enhanced MRI for the prediction of microvascular invasion in solitary hepatocellular carcinoma ≤ 5 cm.Front Oncol2022;12:831795 PMCID:PMC9160991

[99] Zhang W,Liang F.Prediction of microvascular invasion in hepatocellular carcinoma with a multi-disciplinary team-like radiomics fusion model on dynamic contrast-enhanced computed tomography.Front Oncol2021;11:660629 PMCID:PMC8008108

[100] Chu H,Liang W.Radiomics using CT images for preoperative prediction of futile resection in intrahepatic cholangiocarcinoma.Eur Radiol2021;31:2368-76

[101] Limkin EJ,Dercle L.Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology.Ann Oncol2017;28:1191-206

[102] Lopez A,Mizrak Kaya D,Song S.Liquid biopsies in gastrointestinal malignancies: when is the big day?.Expert Rev Anticancer Ther2018;18:19-38

[103] Dalal V,Dhaliwal A,Kaur S.Radiomics in stratification of pancreatic cystic lesions: machine learning in action.Cancer Lett2020;469:228-37

[104] Wu M,Gao F.Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature.Eur Radiol2019;29:2802-11

[105] Ye Z,Chen J.Texture analysis on gadoxetic acid enhanced-MRI for predicting Ki-67 status in hepatocellular carcinoma: a prospective study.Chin J Cancer Res2019;31:806-17

[106] Yao S,Wei Y,Song B.Radiomics in hepatocellular carcinoma: a state-of-the-art review.World J Gastrointest Oncol2021;13:1599-615

[107] Miranda Magalhaes Santos JM,Araujo-Filho JAB.State-of-the-art in radiomics of hepatocellular carcinoma: a review of basic principles, applications, and limitations.Abdom Radiol2020;45:342-53

[108] Castaldo A,Pontillo G.State of the art in artificial intelligence and radiomics in hepatocellular carcinoma.Diagnostics2021;11:1194

[109] Granata V,Belli A.Conventional, functional and radiomics assessment for intrahepatic cholangiocarcinoma.Infect Agent Cancer2022;17:13

[110] Suh SW,Lee JM.Prediction of aggressiveness in early-stage hepatocellular carcinoma for selection of surgical resection.J Hepatol2014;60:1219-24

[111] Kim J,Lee SH,Park H.Predicting survival using pretreatment ct for patients with hepatocellular carcinoma treated with transarterial chemoembolization: comparison of models using radiomics.AJR Am J Roentgenol2018;211:1026-34

[112] Reimer RP,Mahnken AH.Assessment of therapy response to transarterial radioembolization for liver metastases by means of post-treatment MRI-based texture analysis.Cardiovasc Intervent Radiol2018;41:1545-56

[113] Chen S,Wei J.Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imaging.Eur Radiol2019;29:4177-87

[114] Sun R,Vakalopoulou M.A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.Lancet Oncol2018;19:1180-91

[115] Zhou W,Wang K.Malignancy characterization of hepatocellular carcinomas based on texture analysis of contrast-enhanced MR images.J Magn Reson Imaging2017;45:1476-84

[116] Zhou Y,Huang Y.CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma.Abdom Radiol2017;42:1695-704

[117] Hu J,Deng L.Development and validation of a nomogram for predicting the cancer-specific survival of fibrolamellar hepatocellular carcinoma patients.Updates Surg2022;74:1589-99

[118] Liu Q,Liu F.A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.Cancer Imaging2020;20:82

[119] Wang XH,Cui Y.MRI-based radiomics model for preoperative prediction of 5-year survival in patients with hepatocellular carcinoma.Br J Cancer2020;122:978-85

[120] Tabrizian P,Shrager B,Roayaie S.Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis.Ann Surg2015;261:947-55

[121] Ji GW,Xu Q.Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: a multi-institutional study.EBioMedicine2019;50:156-65

[122] Yuan C,Gu D.Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram.Cancer Imaging2019;19:21

[123] Zhang Z,Jiang H.Gadoxetic acid-enhanced MRI radiomics signature: prediction of clinical outcome in hepatocellular carcinoma after surgical resection.Ann Transl Med2020;8:870

[124] Ji GW,Zhang H.Biliary tract cancer at CT: a radiomics-based model to predict lymph node metastasis and survival outcomes.Radiology2019;290:90-8

[125] Peng YT,Lin P.Preoperative ultrasound radiomics signatures for noninvasive evaluation of biological characteristics of intrahepatic cholangiocarcinoma.Acad Radiol2020;27:785-97

[126] Xu L,Liang W.A radiomics approach based on support vector machine using MR images for preoperative lymph node status evaluation in intrahepatic cholangiocarcinoma.Theranostics2019;9:5374-85

[127] Xiang F,Liu X,Yang L.Radiomics analysis of contrast-enhanced CT for the preoperative prediction of microvascular invasion in mass-forming intrahepatic cholangiocarcinoma.Front Oncol2021;11:774117

[128] Zhou Y,Zhang J,Wang X.Radiomics signature on dynamic contrast-enhanced MR images: a potential imaging biomarker for prediction of microvascular invasion in mass-forming intrahepatic cholangiocarcinoma.Eur Radiol2021;31:6846-55

[129] Yang C,Li S.Radiomics model of magnetic resonance imaging for predicting pathological grading and lymph node metastases of extrahepatic cholangiocarcinoma.Cancer Lett2020;470:1-7

[130] Liu Z,Dong D.The applications of radiomics in precision diagnosis and treatment of oncology: opportunities and challenges.Theranostics2019;9:1303-22

[131] Zhao B.Understanding sources of variation to improve the reproducibility of radiomics.Front Oncol2021;11:633176

[132] Fiz F,Gennaro N.Contrast administration impacts CT-based radiomics of colorectal liver metastases and non-tumoral liver parenchyma revealing the “Radiological” tumour microenvironment.Diagnostics2021;11:1162

[133] Lambin P,Deist TM.Radiomics: the bridge between medical imaging and personalized medicine.Nat Rev Clin Oncol2017;14:749-62

[134] Junttila MR.Influence of tumour micro-environment heterogeneity on therapeutic response.Nature2013;501:346-54

[135] O’Connor JPB,Waterton JC,Parker GJM.Imaging intratumor heterogeneity: role in therapy response, resistance, and clinical outcome.Clin Cancer Res2015;21:249-57